You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

busulfan

Showing 26 - 50 of 361
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Leukemia Trial in Shanghai (Busulfan)

Recruiting
  • Acute Leukemia
  • Busulfan
  • Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
May 19, 2021

Genetic Rare Disease Trial in Seoul (Busulfan)

Recruiting
  • Genetic Rare Disease
  • Busulfan
  • Seoul, Daehangno, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
Mar 28, 2021

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell

Completed
  • Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Allogeneic Bone Marrow Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 15, 2021

MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Busulfan
  • +3 more
  • Miami, Florida
    Miami Cancer Institute
Jan 10, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Total Body Irradiation (TBI)
  • +5 more
  • Miami, Florida
    Baptist Health South Florida/Miami Cancer Institute
Nov 28, 2022

Multiple Myeloma Trial in New York (drug, biological, procedure)

Active, not recruiting
  • Multiple Myeloma
  • busulfan
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Congenital Pediatric Disorders Trial in Houston (Busulfan, Cytoxan, Fludarabine)

Active, not recruiting
  • Congenital Pediatric Disorders
  • Busulfan
  • +3 more
  • Houston, Texas
    Texas Children's Hospital
Feb 4, 2022

Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +13 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 8, 2022

Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

Recruiting
  • Fanconi Anemia
  • +2 more
  • Total Body Irradiation (TBI) (Plan 1)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)

Not yet recruiting
  • Stem Cell Transplantation
  • Houston, Texas
    M D Anderson Cancer Center
May 4, 2022

Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,

Recruiting
  • Cutaneous T-cell Lymphoma
  • +4 more
  • Columbus, Ohio
    The Ohio State University Cancer Center
Apr 18, 2022

X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Suspended
  • X-linked Severe Combined Immunodeficiency (XSCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)

Active, not recruiting
  • Graft Versus Host Disease
  • Hematopoietic/Lymphoid Cancer
  • fludarabine phosphate
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Target Busulfan Exposure in Children With HSCT in China

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Busulfan
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Mar 8, 2021

Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

Withdrawn
  • Hematologic Diseases
  • +5 more
  • CliniMACS
  • +7 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Sep 26, 2022

Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

Recruiting
  • Acute Myeloid Leukemia
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022

Myelodysplastic Syndrome, Leukemia, Acute Myeloid Leukemia Trial in Houston (Busulfan, Fludarabine)

Completed
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 12, 2021

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • Busulfan
  • +8 more
  • (no location specified)
Oct 18, 2022

Large B-cell Lymphoma Trial in Tianjin (CNCT19, Gemcitabine Injection, busulfan)

Recruiting
  • Large B-cell Lymphoma
  • CNCT19
  • +3 more
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jan 24, 2022

Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia Trial in Cleveland (radiation, drug, procedure,

Completed
  • Acute Myeloid Leukemia
  • +10 more
  • total marrow irradiation
  • +7 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
May 5, 2021

Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)

Recruiting
  • Acute Leukemia
  • +9 more
  • Total Body Irradiation 1200 cGy
  • +7 more
  • Rochester, New York
    Wilmot Cancer Institute
Jun 20, 2022

Severe Combined Immunodeficiency Disease, X-linked Trial in San Francisco, Memphis, Seattle (genetic, drug, device)

Recruiting
  • Severe Combined Immunodeficiency Disease, X-linked
  • CL20-i4-EF1α-hγc-OPT
  • +2 more
  • San Francisco, California
  • +2 more
Jan 9, 2023

Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

Recruiting
  • Hematologic Malignancy
  • Myeloid Malignancy
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Nov 7, 2022

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022